Related Experiment Video
Updated: May 25, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
[Prophylactic probiotics for preterm infants reduces mortality]
Jesper Brok1, Ole Pryds, Birgitte Smith
1Pædiatrisk Afdeling, Hvidovre Hospital, Denmark. jesperb5@hotmail.com
Insights
Prophylactic probiotics significantly reduce mortality and necrotising enterocolitis in preterm infants. However, clinical use is limited due to unclear mechanisms and safety concerns, despite strong evidence.
Area of Science:
- Neonatal medicine
- Microbiome research
- Clinical trial design
Context:
- Meta-analyses demonstrate significant benefits of prophylactic probiotics for preterm infants, including reduced mortality and necrotising enterocolitis.
- Clinical implementation remains low due to a lack of understanding regarding the beneficial mechanisms.
- Concerns persist regarding safety, long-term effects, and optimal probiotic regimens for preterm neonates.
Purpose:
- To address the reluctance of clinicians to adopt prophylactic probiotics in preterm infants.
- To highlight the ongoing ethical dilemma surrounding current randomized trials on probiotics versus placebo.
- To underscore the gap between robust evidence and clinical practice.
Summary:
- Prophylactic probiotics show significant efficacy in reducing mortality and necrotising enterocolitis in preterm infants.
- Clinician hesitancy stems from poorly understood mechanisms, safety concerns, and undefined optimal treatment protocols.
- Limited adoption is observed globally, with ongoing trials facing ethical considerations regarding their continuation.
Impact:
- The findings highlight the need for further research into probiotic mechanisms and long-term safety in neonates.
- Addressing clinical concerns could facilitate wider adoption of evidence-based probiotic interventions.
- Resolution of ethical dilemmas in ongoing trials is crucial for advancing clinical guidelines.
Abstract:
Meta-analyses indicate that prophylactic probiotics for preterm infants reduces mortality and necrotising enterocolitis significantly. Despite the robust evidence clinicians are reluctant to implement probiotics because the beneficial mechanism is not clearly understood and due to concerns about the safety, the long-term effects, and the optimal treatment regimen. Hence, only few countries and only two-thirds of the Danish neonatal departments use probiotics. Currently three large randomised trials on probiotics vs. placebo are ongoing and it is an ethical dilemma whether to proceed or terminate the trials.
More Related Videos
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Probiotics
Introduction to the Human Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

